Advanced Prostate Cancer Treated with Intermittent or Continuous Androgen Deprivation in the Randomised FinnProstate Study VII – Quality of Life and Adverse Effects



: Quality of Life and Adverse Effects

: Salonen AJ, Taari K, Ala-Opas M, Viitanen J, Lundstedt S, Tammela TLJ, the FinnProstate Group (incl. Laato M Nurmi M)

Publisher: ELSEVIER SCIENCE BV

: 2013

: European Urology

: EUROPEAN UROLOGY

: EUR UROL

: 1

: 63

: 1

: 111

: 120

: 10

: 0302-2838

DOI: https://doi.org/10.1016/j.eururo.2012.07.040


Conclusions: IAD showed benefits in the treatment of advanced PCa with respect to QoL. The prevalence of AEs was not significantly lower with IAD. Trial registration: ClinicalTrials.gov, NCT00293670. (C) 2012 European Association of Urology. Published by Elsevier B. V. All rights reserved.



Last updated on 2024-26-11 at 22:42